logo-loader

IPO Roundup: A $1B German biotech and an Illinois-based bank set to go public this week

BioNTech SE would be the third-largest development-stage biotech to list in the US at its projected IPO price

Nasdaq building
BioNTech SE is developing individualized immunotherapies to treat cancer

Two companies are expected to debut on the Nasdaq this week, each planning to command a nine-figure IPO.

BioNTech SE (NASDAQ:BNTX), a German biotechnology company developing individualized immunotherapies to treat cancer, plans to raise $251 million in its IPO. The company is set to offer 13.2 million shares at a price between $18 and $20 per share.

An IPO of that size would give the company a market cap of $4.45 billion and make it the third-largest development-stage biotech to list in the US, according to broker Renaissance Capital.

Founded in 2008, the company has a drug pipeline of more than 20 product candidates, seven of which have entered into eight clinical trials.

HBT Financial Inc (NASDAQ:HBT), a bank holding company based in Bloomington, Illinois, hopes to raise $149 million by offering 8.3 million shares at a price between $17 and $19 per share. 

As of June 30, HBT had total assets of $3.2 billion. It had loans held for investment of $2.2 billion, total deposits of $2.8 billion and stockholders' equity of $340 million.

Its bank subsidiaries, Heartland Bank and Lincoln Bank, operate 64 branches in central and northeastern Illinois. 

HBT Financial was formerly known as Heartland Bancorp.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Things coming together nicely in Greenland, says Bluejay Mining's CEO

Rod McIllree, Bluejay Mining PLC’s (LON:JAY) chief executive, tells Proactive that all three of its projects in Greenland are shaping up nicely with plenty of interest from mining giants. Dundas is the flagship and here a bulk sample of mineral sands has been shipped to a Rio Tinto facility...

1 day, 9 hours ago

2 min read